IL117495A - History of b-alanine, the process for their preparation and the pharmaceutical preparations containing them - Google Patents

History of b-alanine, the process for their preparation and the pharmaceutical preparations containing them

Info

Publication number
IL117495A
IL117495A IL11749596A IL11749596A IL117495A IL 117495 A IL117495 A IL 117495A IL 11749596 A IL11749596 A IL 11749596A IL 11749596 A IL11749596 A IL 11749596A IL 117495 A IL117495 A IL 117495A
Authority
IL
Israel
Prior art keywords
alkyl
piperidyl
group
compound
ester
Prior art date
Application number
IL11749596A
Other languages
English (en)
Hebrew (he)
Other versions
IL117495A0 (en
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9505437.5A external-priority patent/GB9505437D0/en
Priority claimed from GBGB9524266.5A external-priority patent/GB9524266D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of IL117495A0 publication Critical patent/IL117495A0/xx
Publication of IL117495A publication Critical patent/IL117495A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IL11749596A 1995-03-17 1996-03-14 History of b-alanine, the process for their preparation and the pharmaceutical preparations containing them IL117495A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9505437.5A GB9505437D0 (en) 1995-03-17 1995-03-17 New compound
GBGB9524266.5A GB9524266D0 (en) 1995-11-28 1995-11-28 New compound

Publications (2)

Publication Number Publication Date
IL117495A0 IL117495A0 (en) 1996-07-23
IL117495A true IL117495A (en) 2002-05-23

Family

ID=26306701

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11749596A IL117495A (en) 1995-03-17 1996-03-14 History of b-alanine, the process for their preparation and the pharmaceutical preparations containing them

Country Status (10)

Country Link
US (1) US6384028B1 (ko)
EP (1) EP0869944A1 (ko)
JP (1) JPH11502224A (ko)
KR (1) KR19980703107A (ko)
AR (1) AR002717A1 (ko)
AU (1) AU4954296A (ko)
CA (1) CA2215106A1 (ko)
IL (1) IL117495A (ko)
TW (1) TW406079B (ko)
WO (1) WO1996029309A1 (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010051730A1 (en) * 1993-09-22 2001-12-13 Fujisawa Pharmaceutical Co., Ltd. Beta-alanine derivative and a process for the preparation thereof
WO1997033869A1 (en) * 1996-03-13 1997-09-18 Fujisawa Pharmaceutical Co., Ltd. N-[(r)-1-{3-(4-piperidyl)propionyl-3-piperidylcarbonyl]-2(s)-acetylamino-beta-alanine as fibrinogen receptor antagonist
SI0923555T1 (en) * 1996-05-01 2005-10-31 Ortho-Mcneil Pharmaceutical, Inc. Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
JP4328387B2 (ja) * 1996-05-01 2009-09-09 オーソ―マクニール・フアーマシユーチカル・インコーポレーテツド 血栓形成疾患の処置のためのピロリジン、ピペリジン及びヘキサヒドロアゼピンのカルボキサミド誘導体
US6066651A (en) 1997-10-29 2000-05-23 Ortho-Mcneil Pharmaceutical, Inc. Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders
AU769718B2 (en) * 1998-10-12 2004-02-05 Fujisawa Pharmaceutical Co., Ltd. New processes for producing beta-alanine derivative
AUPP646598A0 (en) * 1998-10-12 1998-11-05 Fujisawa Pharmaceutical Co., Ltd. New processes for producing alpha-alanine derivative
AUPQ570100A0 (en) 2000-02-17 2000-03-09 Fujisawa Pharmaceutical Co., Ltd. Beta-alanine derivatives and their use as receptor antagonists
CA2492035A1 (en) 2002-07-11 2004-01-15 Vicuron Pharmaceuticals, Inc. N-hydroxyamide derivatives possessing antibacterial activity
WO2005019177A1 (en) * 2003-08-14 2005-03-03 Icos Corporation Aminopiperidine amide derivatives as vla-1 integrin antagonists and uses thereof
WO2005079863A1 (ja) * 2004-02-25 2005-09-01 Astellas Pharma Inc. 血栓造影剤
RU2009136330A (ru) 2007-03-01 2011-04-10 Янссен Фармацевтика Н.В. (Be) Тетрагидроизохинолиновые соединения в качестве модуляторов гистаминового н3 рецептора
ES2621379T3 (es) 2011-08-17 2017-07-03 Piramal Imaging Sa Compuestos para la unión a la glicoproteína IIb/IIIa específica de las plaquetas y su utilización para la formación de imágenes de trombos
JP2016508507A (ja) 2013-02-12 2016-03-22 バイエル・ファルマ・アクティエンゲゼルシャフト 血小板特異的糖タンパク質ＩＩｂ／ＩＩＩａに結合するための金属キレート化合物
KR102548998B1 (ko) 2020-03-31 2023-06-29 재단법인 아산사회복지재단 혈전영상을 위한 방사성의약품 및 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053392A (en) * 1989-12-01 1991-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Novel arginine, glycine, aspartic acid derivatives as platelet-aggregation inhibitors
CA2037153A1 (en) * 1990-03-09 1991-09-10 Leo Alig Acetic acid derivatives
US5273982A (en) * 1990-03-09 1993-12-28 Hoffmann-La Roche Inc. Acetic acid derivatives
DK0669912T3 (da) * 1993-09-22 2002-03-04 Fujisawa Pharmaceutical Co N-(3-Piperidinylcarbonyl)-beta-alaninderivater som PAF-antagonister
DE69426602T2 (de) * 1993-10-19 2001-08-30 Sumitomo Pharma 2,3-diaminopropionsäurederivate
US5770575A (en) * 1994-03-16 1998-06-23 Ortho Pharmaceutical Corporation Nipecotic acid derivatives as antithrombotic compounds

Also Published As

Publication number Publication date
IL117495A0 (en) 1996-07-23
AR002717A1 (es) 1998-04-29
CA2215106A1 (en) 1996-09-26
EP0869944A1 (en) 1998-10-14
JPH11502224A (ja) 1999-02-23
TW406079B (en) 2000-09-21
KR19980703107A (ko) 1998-10-15
WO1996029309A1 (en) 1996-09-26
AU4954296A (en) 1996-10-08
US6384028B1 (en) 2002-05-07

Similar Documents

Publication Publication Date Title
US6380215B1 (en) Beta-alanine derivative and a process for the preparation thereof
US6384028B1 (en) N-acylpiperidinylcarbonylaminocarboxylic acids and their use as glycoprotein IIb/IIIa antagonists and fibrinogen-blood platelets binding inhibitors
AU690082B2 (en) 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives asmulti-drug-resistent cancer cell sensitizers
BRPI0616111A2 (pt) composto de carboxamida, seu uso, combinações e intermediários
KR20110017452A (ko) 무스칼린 수용체 길항제로서 활성인 신규한 화합물
US6812235B2 (en) Beta-alanine derivatives and their use as receptor anatgonists
US6538007B1 (en) N-[(R)-1-[3-(4-piperidyl)propionyl]-3-piperidylcarbonyl]-2(S)-acetylamino-β-alanine trihydrate, compositions thereof, and methods for its use
JP3874438B2 (ja) 置換β−アミノ酸残基を有するフィブリノーゲン受容体拮抗物質およびそれを有効成分とする医薬製剤
WO1986000066A1 (en) N-substituted butyramide derivatives
JP2713246B2 (ja) β−アラニン誘導体およびその製造法
US20010051730A1 (en) Beta-alanine derivative and a process for the preparation thereof
JPH08277285A (ja) ピペリジン化合物、その製造法およびその用途
JPH09194460A (ja) 窒素含有複素環化合物、その製造法およびその用途
JPH08283260A (ja) ピリダジノン誘導体及びその製造法
MXPA01003683A (en) NEW PROCESSES FOR PRODUCING&bgr;-ALANINE DERIVATIVE
AU6004499A (en) New processes for producing beta-alanine derivative

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HC Change of name of proprietor(s)
MM9K Patent not in force due to non-payment of renewal fees